Interest in Evaluating Primary Hemostasis in Patients With Veno-venous Extracorporeal Membrane Oxygenation (ECMO)

Interest in Evaluating Primary Hemostasis in Patients With Veno-venous Extracorporeal Membrane Oxygenation (ECMO)

The aim of the study is a better understanding of hemorrhagic events causes in patients with ECMO, prevent them and decrease the number of transfusion.

The most frequent complication during ECMO is hemorrhage especially as a curative anticoagulant treatment is necessary. The primary hemostasis is also affected with a von Willebrand disease and thrombopathy, well known but not studied by recent tests.The identification of primary haemostasis deficits with these tools would allow to supply them and decrease the morbi-mortality related to the transfusion.

Inclusion Criteria:

• Patient older than 18 years old
• Patient with ECMO
• Patient hospitalized in an intensive care unit at the University Hospital of Rennes

Exclusion Criteria:

• Known history for constitutional pathology of the primary haemostasis
• Platelets < 100000 / mm3 or hematocrit < 28 % between H+12 and H+24